Abstract
AMP-activated protein kinase (AMPK) is an important therapeutic target for the potential treatment of metabolic disorders, cardiovascular disease and cancer. Recently, various classes of compounds that activate AMPK by direct or indirect interactions have been reported. The importance of computer-aided drug design approaches in the search for potent activators of AMPK is now established, including structure-based design, ligand-based design, fragment-based design, as well as structural analysis. This review article highlights the computer-aided drug design approaches utilized to discover of activators targeting AMPK. The principles, advantages or limitation of the different methods are also being discussed together with examples of applications taken from the literatures.
Keywords: AMP-activated protein kinase, activator, structure-based drug design, ligand-based drug design, fragment-based, drug design, structural analysis, fragment-based drug design, QSAR, pharmacophore modellng, molecular docking, virtual screening
Current Computer-Aided Drug Design
Title: Computer-Aided Drug Design for AMP-Activated Protein Kinase Activators
Volume: 7 Issue: 3
Author(s): Zhanli Wang, Jianxin Huo, Lidan Sun, Yongfu Wang, Hongwei Jin, Hui Yu, Liangren Zhang and Lishe Zhou
Affiliation:
Keywords: AMP-activated protein kinase, activator, structure-based drug design, ligand-based drug design, fragment-based, drug design, structural analysis, fragment-based drug design, QSAR, pharmacophore modellng, molecular docking, virtual screening
Abstract: AMP-activated protein kinase (AMPK) is an important therapeutic target for the potential treatment of metabolic disorders, cardiovascular disease and cancer. Recently, various classes of compounds that activate AMPK by direct or indirect interactions have been reported. The importance of computer-aided drug design approaches in the search for potent activators of AMPK is now established, including structure-based design, ligand-based design, fragment-based design, as well as structural analysis. This review article highlights the computer-aided drug design approaches utilized to discover of activators targeting AMPK. The principles, advantages or limitation of the different methods are also being discussed together with examples of applications taken from the literatures.
Export Options
About this article
Cite this article as:
Wang Zhanli, Huo Jianxin, Sun Lidan, Wang Yongfu, Jin Hongwei, Yu Hui, Zhang Liangren and Zhou Lishe, Computer-Aided Drug Design for AMP-Activated Protein Kinase Activators, Current Computer-Aided Drug Design 2011; 7 (3) . https://dx.doi.org/10.2174/157340911796504323
DOI https://dx.doi.org/10.2174/157340911796504323 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
New Generation of Orally Disintegrating Tablets for Sustained Drug Release: A Propitious Outlook
Current Drug Delivery Marine Natural Products as a Promising Source of Therapeutic Compounds to Target Cancer Stem Cells
Current Medicinal Chemistry Cervical Cancer Diagnosis: Insights into Biochemical Biomarkers and Imaging Techniques
Combinatorial Chemistry & High Throughput Screening The Role of Mineral Deficiencies in Insulin Resistance and Obesity
Current Diabetes Reviews The Characteristics, Functions and Inhibitors of Three Aminopeptidases Belonging to the M1 Family
Current Protein & Peptide Science Cardiac Complications in Hypertension and Diabetes: Role of Sympathetic Nervous Activity
Current Hypertension Reviews Lycopene Modulation of Molecular Targets Affected by Smoking Exposure
Current Cancer Drug Targets In Silico hERG Modeling: Challenges and Progress
Current Computer-Aided Drug Design Endobronchial Ultrasound-guided Transbronchial Needle Aspiration
Reviews on Recent Clinical Trials Identification of Candidate Biomarkers of Acute Aortic Dissection
Recent Patents on DNA & Gene Sequences Patenting Penicillium Strains
Recent Patents on Biotechnology Diabetes Trends in Hospitalized HIV-Infected Persons in the United States, 1994-2004
Current HIV Research The First Approved Agent in the Glitazar’s Class: Saroglitazar
Current Drug Targets Catestatin: A Master Regulator of Cardiovascular Functions
Current Medicinal Chemistry Cytochrome P450 and the Biological Clock in Mammals
Current Drug Metabolism Endothelial Activation. Sliding Door to Atherosclerosis
Current Pharmaceutical Design Lipoprotein(a) is a Therapeutic Target for Cardiovascular Disease
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Efficacy and Safety of Evacetrapib for Modifying Plasma Lipids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Current Pharmaceutical Design The Effects of Obesity-Related Peptides on the Vasculature
Current Vascular Pharmacology Subject Index to Volume 9
Current Pharmaceutical Design